FDA Classifies Anti-Mullerian Hormone Test System into Class II Special Controls

Summary

The FDA is classifying the anti-mullerian hormone test system into Class II special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.